The invention provides immunoconjugates of Formula I comprising an antibody linked by conjugation to one or more 2-amino-4-carboxamide-benzazepine derivatives. The invention also provides 2-amino-4-carboxamide-benzazepine derivative intermediate compositions comprising a reactive functional group. Such intermediate compositions are suitable substrates for formation of the immunoconjugates through a linker or linking moiety. The invention further provides methods of treating cancer with the immunoconjugates.
本发明提供了式I的免疫结合物,其中包括通过共轭连接与一种或多种2-
氨基-4-羧酰胺苯并二氮平衍
生物链接的
抗体。本发明还提供了2-
氨基-4-羧酰胺苯并二氮平衍
生物中间体组合物,其中包括反应性官能团。这样的中间体组合物是通过连接物或连接基物质的形成适合于形成免疫结合物的底物。本发明还提供了使用免疫结合物治疗癌症的方法。